Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Stockholm - Free Realtime Quote SEK

BioInvent International AB (publ) (BINV.ST)

Compare
28.30
-0.15
(-0.53%)
As of 11:47:19 AM GMT+2. Market Open.
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
44,686
44,686
71,461
326,126
19,384
Operating Expense
515,745
515,745
442,018
376,598
297,549
Operating Income
-471,059
-471,059
-370,557
-50,472
-278,165
Net Non Operating Interest Income Expense
--
--
39,967
8,422
-253
Pretax Income
-429,240
-429,240
-330,100
-42,503
-278,444
Tax Provision
135
135
204
--
--
Net Income Common Stockholders
-429,375
-429,375
-330,304
-42,503
-278,444
Diluted NI Available to Com Stockholders
-429,375
-429,375
-330,304
-42,503
-278,444
Basic EPS
-6.53
--
-5.02
-0.69
-5.14
Diluted EPS
-6.53
--
-5.02
-0.69
-5.14
Basic Average Shares
65,754.21
--
65,797.61
61,521
54,161
Diluted Average Shares
65,754.21
--
65,797.61
61,521
54,161
Total Operating Income as Reported
-471,059
-471,059
-369,942
-50,921
-278,350
Total Expenses
515,745
515,745
442,018
376,598
297,549
Net Income from Continuing & Discontinued Operation
-429,375
-429,375
-330,304
-42,503
-278,444
Normalized Income
-462,579.29
-462,579.29
-330,304
-42,503
-278,444
Interest Income
--
--
40,605
9,072
264
Interest Expense
--
--
638
650
517
Net Interest Income
--
--
39,967
8,422
-253
EBIT
-471,059
-471,059
-329,462
-41,853
-277,927
EBITDA
-451,759
-451,759
-312,707
-27,129
-263,317
Reconciled Depreciation
19,300
19,300
16,755
14,724
14,610
Net Income from Continuing Operation Net Minority Interest
-429,375
-429,375
-330,304
-42,503
-278,444
Total Unusual Items Excluding Goodwill
41,819
41,819
--
--
--
Total Unusual Items
41,819
41,819
--
--
--
Normalized EBITDA
-493,578
-493,578
-312,707
-27,129
-263,317
Tax Rate for Calcs
0
0
0
--
--
Tax Effect of Unusual Items
8,614.71
8,614.71
--
--
--
12/31/2021 - 6/12/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACTI.ST Active Biotech AB (publ)
0.0809
-2.18%
 
CTX.WA Captor Therapeutics Spolka Akcyjna
38.30
-3.77%
 
BSLNz.XC
 
RFM.F Sensorion SA
0.3890
+7.76%
 
CAMX.ST Camurus AB (publ)
585.00
+2.09%
 
OCS Oculis Holding AG
18.30
-1.93%
 
XBRANE.ST Xbrane Biopharma AB (publ)
0.1948
-0.10%
 
BIOSGN.ST Biosergen AB
0.3400
-5.29%
 
BCTXW BriaCell Therapeutics Corp.
0.1019
+14.88%
 
XSPRAY.ST Xspray Pharma AB (publ)
29.70
-2.30%